FDA approvals

GSK
Pharma

GSK talks through Hibsago launch as it reports out mixed Q3

Armed with a trio of recent high-profile approvals, GSK is banking on its specialty medicines to drive its next wave of growth.
Fraiser Kansteiner Oct 28, 2026 11:05am
Close-up of human eye

Roche's Enspryng muscles in on Tepezza's TED turf

Oct 16, 2026 9:26am
sale transaction MA deal changing hands money money changing hands

Ultragenyx cashes in a pair of FDA review vouchers for $413M

Oct 14, 2026 4:19pm
Eli Lillys booth at ASH 2025 prominently featuring Jaypirca

Lilly’s BTK drug Jaypirca enters first-line CLL

Oct 2, 2026 4:15pm
brain

FDA approves Otsuka’s first-in-class ADHD drug Simtriyo

Jul 27, 2026 12:42pm
GSK

Nuvalent deal delivers GSK’s first-ever lung cancer approval

Jul 22, 2026 3:15pm